Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis
详细信息 查看全文
- 作者：Ashish Aggarwal (1)
Aman Sharma (2)
Archana Bhatnagar (1) - 关键词：Caspase ; 3 ; Cytokines ; Granzyme ; Perforin ; Reactive oxygen species
- 刊名：Clinical Rheumatology
- 出版年：2014
- 出版时间：August 2014
- 年：2014
- 卷：33
- 期：8
- 页码：1067-1078
- 全文大小：1,041 KB
- 参考文献：1. Maini RN (1998) Rheumatoid arthritis. A paradigm of inflammatory disease of the musculoskeletal system. Acta Orthop Scand Suppl 281:6鈥?3
2. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L (2006) Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 18(6):650鈥?55. doi:10.1016/j.coi.2006.06.004 CrossRef
3. Vivier E, Nunes JA, Vely F (2004) Natural killer cell signaling pathways. Science 306(5701):1517鈥?519. doi:10.1126/science.1103478 CrossRef
4. Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG (2002) The natural killer cell 鈥?friend or foe in autoimmune disease? Scand J Immunol 55(5):432鈥?41 CrossRef
5. Kang H, Han BS, Kim SJ, Oh YJ (2012) Mechanisms to prevent caspase activation in rotenone-induced dopaminergic neurodegeneration: role of ATP depletion and procaspase-9 degradation. Apoptosis. doi:10.1007/s10495-012-0699-0
6. Heibein JA, Goping IS, Barry M, Pinkoski MJ, Shore GC, Green DR, Bleackley RC (2000) Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med 192(10):1391鈥?402 CrossRef
7. Ronday HK, van der Laan WH, Tak PP, de Roos JA, Bank RA, TeKoppele JM, Froelich CJ, Hack CE, Hogendoorn PC, Breedveld FC, Verheijen JH (2001) Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford) 40(1):55鈥?1 CrossRef
8. Romero V, Andrade F (2008) Non-apoptotic functions of granzymes. Tissue Antigens 71(5):409鈥?16. doi:10.1111/j.1399-0039.2008.01013.x CrossRef
9. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, Kim S, Raja SM, Shi L, Simon MM, Froelich CJ (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29(5):720鈥?33. doi:10.1016/j.immuni.2008.08.014 CrossRef
10. Froelich CJ, Zhang X, Turbov J, Hudig D, Winkler U, Hanna WL (1993) Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J Immunol 151(12):7161鈥?171
11. Chowdhury D, Lieberman J (2008) Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 26:389鈥?20. doi:10.1146/annurev.immunol.26.021607.090404 CrossRef
12. Sower LE, Klimpel GR, Hanna W, Froelich CJ (1996) Extracellular Activities of Human Granzymes. Cell Immunol 171(1):159鈥?63 CrossRef
13. de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ (2009) Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 60(9):2782鈥?793. doi:10.1002/art.24750 CrossRef
14. Shegarfi H, Naddafi F, Mirshafiey A (2012) Natural killer cells and their role in rheumatoid arthritis: friend or foe? Sci World J 2012:491974. doi:10.1100/2012/491974 CrossRef
15. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Ljunggren HG (2009) Natural killer cells in human autoimmunity. Curr Opin Immunol 21(6):634鈥?40. doi:10.1016/j.coi.2009.09.012 CrossRef
16. Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, Wu CY, Zheng BJ, Lu L (2008) Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum 58(9):2700鈥?711. doi:10.1002/art.23760 CrossRef
17. Soderstrom K, Stein E, Colmenero P, Purath U, Muller-Ladner U, de Matos CT, Tarner IH, Robinson WH, Engleman EG (2010) Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A 107(29):13028鈥?3033. doi:10.1073/pnas.1000546107 CrossRef
18. Aramaki T, Ida H, Izumi Y, Fujikawa K, Huang M, Arima K, Tamai M, Kamachi M, Nakamura H, Kawakami A, Origuchi T, Matsuoka N, Eguchi K (2009) A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod Rheumatol 19(3):245鈥?52. doi:10.1007/s10165-009-0160-6 CrossRef
19. Lunemann A, Lunemann JD, Munz C (2009) Regulatory NK-cell functions in inflammation and autoimmunity. Mol Med 15(9鈥?0):352鈥?58. doi:10.2119/molmed.2009.00035
20. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, Shin MH, Park JJ, Kim TJ, Lee SS, Yoo DH, Kang HS (2009) Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 60(6):1753鈥?763. doi:10.1002/art.24556 CrossRef
21. Paust S, Senman B, von Andrian UH (2010) Adaptive immune responses mediated by natural killer cells. Immunol Rev 235(1):286鈥?96. doi:10.1111/j.0105-2896.2010.00906.x
22. Godfrey DI, Kinder SJ, Silvera P, Baxter AG (1997) Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR鈭扖D8鈭?thymocytes. J Autoimmun 10(3):279鈥?85 CrossRef
23. Peng SL (2006) Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) 45(1):26鈥?0. doi:10.1093/rheumatology/kei113 CrossRef
24. Ivashchenko O, Van Veldhoven PP, Brees C, Ho YS, Terlecky SR, Fransen M (2011) Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk. Mol Biol Cell 22(9):1440鈥?451. doi:10.1091/mbc.E10-11-0919 CrossRef
25. Kregel KC, Zhang HJ (2007) An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292(1):R18鈥揜36. doi:10.1152/ajpregu.00327.2006 CrossRef
26. Shah D, Kiran R, Wanchu A, Bhatnagar A (2010) Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett 129(1):7鈥?2. doi:10.1016/j.imlet.2010.01.005 CrossRef
27. Shah D, Aggarwal A, Bhatnagar A, Kiran R, Wanchu A (2011) Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res 45(5):559鈥?67. doi:10.3109/10715762.2011.555765 CrossRef
28. Shah D, Wanchu A, Bhatnagar A (2011) Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 216(9):1010鈥?017. doi:10.1016/j.imbio.2011.04.001 CrossRef
29. Minhas U, Minz R, Das P, Bhatnagar A (2012) Therapeutic effect of / Withania somnifera on pristane-induced model of SLE. Inflammopharmacology 20(4):195鈥?05. doi:10.1007/s10787-011-0102-8 CrossRef
30. Mellqvist UH, Hansson M, Brune M, Dahlgren C, Hermodsson S, Hellstrand K (2000) Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96(5):1961鈥?968
31. Winyard PG, Ryan B, Eggleton P, Nissim A, Taylor E, Lo Faro ML, Burkholz T, Szabo-Taylor KE, Fox B, Viner N, Haigh RC, Benjamin N, Jones AM, Whiteman M (2011) Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochem Soc Trans 39(5):1226鈥?232. doi:10.1042/BST0391226 CrossRef
32. Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7(7):567鈥?73. doi:10.1016/j.autrev.2008.04.019 CrossRef
33. Ferrer PE, Frederick P, Gulbis JM, Dewson G, Kluck RM (2012) Translocation of a bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for bak and bax apoptotic function. PLoS One 7(3):e31510. doi:10.1371/journal.pone.0031510 CrossRef
34. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9(3):231鈥?41. doi:10.1038/nrm2312 CrossRef
35. Caligiuri MA (2008) Human natural killer cells. Blood 112(3):461鈥?69. doi:10.1182/blood-2007-09-077438 CrossRef
36. Tarazona R, DelaRosa O, Peralbo E, Casado JG, Pena J, Solana R (2003) Human NKT cells in health and disease. Immunologia 22(4):359鈥?70
37. Vastert SJ, van Wijk R, D'Urbano LE, de Vooght KM, de Jager W, Ravelli A, Magni-Manzoni S, Insalaco A, Cortis E, van Solinge WW, Prakken BJ, Wulffraat NM, de Benedetti F, Kuis W (2010) Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 49(3):441鈥?49. doi:10.1093/rheumatology/kep418 CrossRef
38. Cho BA, Sim JH, Park JA, Kim HW, Yoo WH, Lee SH, Lee DS, Kang JS, Hwang YI, Lee WJ, Kang I, Lee EB, Kim HR (2012) Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis. J Clin Immunol 32(4):709鈥?20. doi:10.1007/s10875-012-9674-3 CrossRef
39. Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB (2004) Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50(11):3663鈥?667. doi:10.1002/art.20613 CrossRef
40. Dinarello CA (2007) Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 27(1):98鈥?14. doi:10.1016/j.semnephrol.2006.09.013 CrossRef
41. Lin NY, Beyer C, Giessl A, Kireva T, Scholtysek C, Uderhardt S, Munoz LE, Dees C, Distler A, Wirtz S, Kronke G, Spencer B, Distler O, Schett G, Distler JH (2013) Autophagy regulates TNFalpha-mediated joint destruction in experimental arthritis. Ann Rheum Dis 72(5):761鈥?68. doi:10.1136/annrheumdis-2012-201671 CrossRef
42. Haugeberg G, Conaghan PG, Quinn M, Emery P (2009) Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Ann Rheum Dis 68(12):1898鈥?901. doi:10.1136/ard.2008.106484 CrossRef
43. Zhang W, Cong XL, Qin YH, He ZW, He DY, Dai SM (2013) IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 36(1):103鈥?09. doi:10.1007/s10753-012-9524-8 CrossRef
44. Karonitsch T, von Dalwigk K, Steiner CW, Bluml S, Steiner G, Kiener HP, Smolen JS, Aringer M (2012) Interferon signals and monocytic sensitization of the interferon-gamma signaling pathway in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 64(2):400鈥?08. doi:10.1002/art.33347 CrossRef
45. van Baarsen LG, Bos WH, Rustenburg F, van der Pouw Kraan TC, Wolbink GJ, Dijkmans BA, van Schaardenburg D, Verweij CL (2010) Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. Arthritis Rheum 62(3):694鈥?04. doi:10.1002/art.27294 CrossRef
46. Cantaert T, van Baarsen LG, Wijbrandts CA, Thurlings RM, van de Sande MG, Bos C, van der Pouw TK, Verweij CL, Tak PP, Baeten DL (2010) Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis. Rheumatology (Oxford) 49(1):156鈥?66. doi:10.1093/rheumatology/kep345 CrossRef
47. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K (1991) Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 10(4):245鈥?52
48. Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ (2009) Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology 55(3):250鈥?58. doi:10.1159/000164393 CrossRef
49. Wilke CM, Bishop K, Fox D, Zou W (2011) Deciphering the role of Th17 cells in human disease. Trends Immunol 32(12):603鈥?11. doi:10.1016/j.it.2011.08.003 CrossRef
50. Balsa A, Del Amo J, Blanco F, Caliz R, Silva L, Sanmarti R, Martinez FG, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Collado MD, Andreu JL, Graell E, Simon L, Martinez A, Mulero J (2010) Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. Rheumatology (Oxford) 49(3):458鈥?66. doi:10.1093/rheumatology/kep380 CrossRef
51. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, Wasco MJ, Fox DA (2009) Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 11(5):R158. doi:10.1186/ar2838 CrossRef
52. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31:227鈥?58. doi:10.1146/annurev-immunol-020711-075005 CrossRef
53. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580鈥?588. doi:10.1136/ard.2010.138461 CrossRef
54. Prevoo ML, van鈥檛 Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44鈥?8 CrossRef
55. Kay HD (1980) A new procedure to overlay diluted blood on Ficoll-hypaque gradients. J Immunol Methods 39(1鈥?):81鈥?3
56. Lanier LL, Testi R, Bindl J, Phillips JH (1989) Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169(6):2233鈥?238 CrossRef
57. Sarkar M, Varshney R, Chopra M, Sekhri T, Adhikari JS, Dwarakanath BS (2006) Flow-cytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patients with thyroid dysfunction. Cytometry B Clin Cytom 70(1):20鈥?3. doi:10.1002/cyto.b.20082 CrossRef - 作者单位：Ashish Aggarwal (1)
Aman Sharma (2)
Archana Bhatnagar (1)
1. Department of Biochemistry, Basic Medical Sciences Block, Panjab University, Chandigarh, India
2. Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India - ISSN：1434-9949
文摘
Innate immunity has been widely accepted as one of the major cause for the alteration of immune system and progression of autoimmune diseases. Natural killer (NK) cells and natural killer T (NKT) cells have not been explored in clinical studies for their cytolytic components in association with rheumatoid arthritis (RA). The literature available for these potential candidates is controversial in terms of their protective or pathogenic role in disease severity of RA. Present study explained the role of NK and NKT cell populations and intracellular expression of caspases, perforin, granzymes A and B in the pathogenesis of RA in patients. DAS28 score was measured as the disease severity. Immunochemical parameters were studied by using monoclonal antibodies (mAbs) against different cell types in flow cytometry. Results indicated that that whatsoever is the change in percentage cell populations, ratio of NK and NKT cell populations always remained poised even in the disease state. Reactive oxygen species (ROS) levels were elevated with increased intracellular active caspase-3, perforin and granzyme expression in RA patients. Their elevated expressions were positively correlated with DAS28 suggesting the pathogenic role in RA. The expressions of pro-inflammatory cytokines were enhanced while the anti-inflammatory cytokine expressions were diminished in the patients. Present study may point towards futuristic therapeutic targets which can fascinate the pharmaceutical industries to selectively target these molecules in designing the therapeutic strategy of RA patients.